Trualt Bioenergy Intrinsic Value
Trualt Bioenergy (TRUALT) median intrinsic value is ₹361.88 from 9 valuation models (range ₹183–₹540), vs current price ₹421.70 — -14.2% downside (Trading Above Median Value), margin of safety -16.5%. Check Trualt Bioenergy networth to track the company's total market size over time.
TRUALT Valuation Methods Summary — DCF, Graham Number & P/E
Trualt Bioenergy intrinsic value across 9 models vs current price ₹421.70 — upside/downside and value range per method. For current market price and key ratios, visit Trualt Bioenergy share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹380.64 | ₹304.51 - ₹456.77 | -9.7% | EPS: ₹31.72, Sector P/E: 12x |
| Book Value Method | asset | ₹183.49 | ₹165.14 - ₹201.84 | -56.5% | Book Value/Share: ₹183.49, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹233.30 | ₹209.97 - ₹256.63 | -44.7% | Revenue/Share: ₹291.63, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹449.30 | ₹404.37 - ₹494.23 | +6.5% | EBITDA: ₹644.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹540.17 | ₹432.14 - ₹648.20 | +28.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹203.01 | ₹182.71 - ₹223.31 | -51.9% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹261.37 | ₹235.23 - ₹287.51 | -38.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹449.30 | ₹404.37 - ₹494.23 | +6.5% | ROE: 17.5%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹361.88 | ₹325.69 - ₹398.07 | -14.2% | EPS: ₹31.72, BVPS: ₹183.49 |
TRUALT Intrinsic Value vs Market Price — All Valuation Models
Trualt Bioenergy fair value range ₹183–₹540 vs current market price ₹421.70 across 9 valuation models. See TRUALT price book multiple to compare market price against book value per share.
TRUALT Intrinsic Value Analysis — Undervalued or Overvalued?
Trualt Bioenergy median intrinsic value ₹361.88, current price ₹421.70 — Trading Above Median Value by 14.2%, margin of safety -16.5%.
What is the intrinsic value of TRUALT?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Trualt Bioenergy (TRUALT) is ₹361.88 (median value). With the current market price of ₹421.70, this represents a -14.2% variance from our estimated fair value.
The valuation range spans from ₹183.49 to ₹540.17, indicating ₹183.49 - ₹540.17.
Is TRUALT undervalued or overvalued?
Based on our multi-method analysis, Trualt Bioenergy (TRUALT) appears to be trading above median value by approximately 14.2%.
TRUALT Financial Health — Key Ratios vs Industry Benchmarks
Trualt Bioenergy financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.33 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 17.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 22.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.66x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
TRUALT Cash Flow Quality — Operating & Free Cash Flow
Trualt Bioenergy operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-296 Cr | ₹-503 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹342 Cr | ₹215 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹36 Cr | ₹-156 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹234 Cr | ₹-341 Cr | Positive Operating Cash Flow | 6/10 |